A Post-Marketing Clinical Study of LY450190 (Combined With Alpha1 Blocker Treatment)

Trial Profile

A Post-Marketing Clinical Study of LY450190 (Combined With Alpha1 Blocker Treatment)

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 19 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 May 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
    • 05 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top